๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Efficacy and safety of a novel delayed-release risedronate 35

โœ Scribed by M. R. McClung; P. D. Miller; J. P. Brown; J. Zanchetta; M. A. Bolognese; C. L. Benhamou; A. Balske; D. E. Burgio; J. Sarley; L. K. McCullough; R. R. Recker

Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
346 KB
Volume
23
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Efficacy and safety of novel antipsychot
Efficacy and safety of novel antipsychotics: a critical review
โœ Matteo Balestrieri; Claudio Vampini; Cesario Bellantuono ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB

Efficacy and safety of novel antipsychotic (AP) drugs (amisulpride, olanzapine, quetiapine, ziprasidone and zotepine) have been reviewed. Data on their antipsychotic efficacy and side effects profile have been evaluated only on the basis of controlled trials so far published. Overall, all these drug

Comparative clinical efficacy and safety
Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain
โœ Neil A. Hagen; Najib Babul ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 210 KB ๐Ÿ‘ 2 views

Fredphone, each given every 12 hours for 7 days. Pain intensity, nausea, and sedation erick, Pickering, Ontario, Canada. were assessed by patients four times daily, and breakthrough analgesia was recorded. ## RESULTS. Thirty-one patients completed the study (18 women, 13 men; mean age, 56 { 3 ye